Makoto Koike
Overview
Explore the profile of Makoto Koike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
83
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yamaguchi E, Sato Y, Oe T, Nishi T, Koike M, Kitakado Y, et al.
Clin J Gastroenterol
. 2015 Apr;
8(2):82-7.
PMID: 25823931
Small cell carcinoma of the stomach, which is considered synonymous with neuroendocrine carcinoma, is rare. We encountered a case of mixed adenoneuroendocrine carcinoma. Gastrointestinal endoscopy revealed a type 0 IIa...
12.
Mukai T, Hikino H, Koike M, Murata Y
Gan To Kagaku Ryoho
. 2012 Mar;
39(3):441-4.
PMID: 22421776
We report a case of recurrent hormone receptor-positive breast cancer with brain metastases that showed good response to vinorelbine(VNR)and anastrozole(ANA). A 49-year-old woman with a history of left breast cancer...
13.
Omori H, Hatamochi A, Koike M, Sato Y, Kosho T, Kitakado Y, et al.
Surg Today
. 2011 May;
41(5):733-6.
PMID: 21533953
The vascular type of Ehlers-Danlos syndrome (vEDS) is a rare inherited disease of the connective tissues, and is caused by abnormal type III collagen resulting from heterogeneous mutations of the...
14.
Nio Y, Iguchi C, Itakura M, Nishi T, Hashimoto K, Takeda H, et al.
Anticancer Res
. 2009 Aug;
29(8):3329-35.
PMID: 19661352
Background: Advanced or recurrent pancreatic cancer can sometimes cause obstruction or stenosis of the portal vein (PV), resulting in various symptoms of portal hypertension (PH), such as ascites, pancytopenia, hemorrhagic...
15.
Nio Y, Iguchi C, Itakura M, Toga T, Hashimoto K, Koike M, et al.
Anticancer Res
. 2009 May;
29(5):1607-10.
PMID: 19443373
Background: Although many reports indicated an association between thyroid diseases and breast cancer, such an association still remains controversial. The present study was aimed to clarify the association of thyroid...
16.
Nio Y, Iguchi C, Kodama H, Itakura M, Hashimoto K, Koike M, et al.
Oncol Rep
. 2006 Dec;
17(1):153-9.
PMID: 17143493
The present study assesses the effects of neo-adjuvant chemotherapy (NAC) with uracil and tegafur (UFT) alone vs UFT plus cyclophosphamide (CPA), on the activity of thymidylate synthase (TS) and dihydropyrimidine...
17.
Ogo Y, Nio Y, Yano S, Toga T, Koike M, Hashimoto K, et al.
Anticancer Res
. 2006 Jun;
26(1B):763-70.
PMID: 16739351
The clinicopathological significance of HER-1- and HER-2-overexpressions (OE) (HercepTest score 2+ or 3+) in biliary cancer and their relationship to the efficacy of adjuvant chemotherapy (ACT) were assessed. In 72...
18.
Kataoka Y, Nio Y, Yano S, Koike M, Hashimoto K, Itakura M, et al.
Gan To Kagaku Ryoho
. 2006 Apr;
33(4):525-8.
PMID: 16612167
Pancreatic acinar cell carcinomas are rare, and little is reported on their chemotherapy. We report a 49-year old male patient with pancreatic acinar cell carcinoma and multiple liver metastases, which...
19.
Nio Y, Omori H, Hashimoto K, Itakura M, Koike M, Yano S, et al.
Anticancer Res
. 2005 Aug;
25(5):3523-9.
PMID: 16101174
Background: The receptor tyrosine kinase c-kit is known to play an important role in the progression of gastrointestinal stromal tumors, but its biological significance in other solid malignancies is unclear....
20.
Nio Y, Hashimoto K, Yano S, Itakura M, Koike M, Yamaguchi K, et al.
Oncol Rep
. 2005 Jul;
14(2):401-8.
PMID: 16012722
The present study assessed the anti-tumor effects and clinical benefits of intravenous (i.v.) or intra-arterial (i.a.) gemcitabine (GEM) at low dose plus oral chemotherapy with uracil-tegafur (UFT) and cyclophosphamide (CPA)...